Which mood stabilisers are friendly for ADHD symptoms?

PostedNovember 20, 2025

UpdatedNovember 21, 2025

ByMy Patient Advice

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

For many adults with ADHD, managing coexisting mood instability or bipolar-type symptoms can be complex. While standard ADHD medicines such as stimulants and atomoxetine remain in first-line treatments, mood stabilisers are sometimes introduced when mood dysregulation or bipolar disorder is also present. According to UK NICE guidance and NHS clinical frameworks, these medicines are not prescribed to treat ADHD itself but to support mood balance in people whose symptoms extend beyond core attention or impulsivity challenges.

Understanding the role of mood stabilisers in ADHD

Mood stabilisers such as lithium, valproate, lamotrigine, and carbamazepine are sometimes used alongside ADHD medication when emotional volatility or comorbid bipolar features make treatment more difficult. Evidence from The Lancet Psychiatry (2025) and PubMed Central indicates that stabilising mood can help reduce extreme irritability or emotional swings that sometimes accompany ADHD. However, NICE and NHS specialists advise that these medicines do not improve core ADHD symptoms like inattention or hyperactivity, so they are reserved for comorbidity cases where mood control is clinically essential.

Mood stabilisers in ADHD with comorbid mood disorders

When ADHD coexists with bipolar disorder, lithium and valproate are most often prescribed to reduce manic or hypomanic episodes before stimulant therapy begins. Lamotrigine and carbamazepine are sometimes considered for mood lability and treatment-resistant emotional dysregulation. Stimulants such as methylphenidate can still be used, but clinicians typically combine them with a mood stabiliser to minimise risk of mood destabilisation. In people where anxiety or depression dominate, non-stimulant options like atomoxetine may be more appropriate under NICE and NHS direction.

NICE and NHS guidance on combining treatments

According to NICE NG87 and NHS shared-care protocols, the use of both mood stabilisers and ADHD medication should only occur under specialist supervision. Combination therapy must be carefully titrated and reviewed regularly to monitor side effects and ensure safety. The Royal College of Psychiatrists advises clinicians to document clear clinical reasoning when prescribing outside standard NICE recommendations, ensuring transparency and patient safety.

Effects and cautions

Findings from The Lancet Psychiatry (2025) and PubMed Central suggest that mood stabilisers can help regulate emotional intensity but have mixed or negligible effects on ADHD’s attention and impulsivity symptoms. Side effects like sedation, weight gain, or slowed thinking are not uncommon. NICE and NHS protocols stress that lithium requires regular blood monitoring due to toxicity risk, while valproate remains restricted in women of childbearing age because of teratogenicity.

Key takeaway

Mood stabilisers can be helpful for people who have ADHD alongside mood or bipolar disorders, but they are not a treatment for ADHD itself. These medicines should only be prescribed under expert supervision, following NICE and NHS protocols. For individuals seeking comprehensive ADHD assessment and medication review, private providers such as ADHD Certify offer structured diagnostic services aligned with national clinical standards.

Harriet Winslow, BSc

Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.